Skip to content
10-K

Annual Report

Gene Biotherapeutics, Inc.

0001564590-17-014409

← back to feed
Filed
Jul 28, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2016 · Jul 28, 2017 14.37M sh
Capex FY 2016 · Dec 31, 2016 $171.73K
Cash And Equivalents FY 2016 · Dec 31, 2016 $930.4K
Cash And Equivalents FY 2016 · Dec 31, 2015 $21.55K
Cash And Equivalents FY 2016 · Dec 31, 2014 $216.73K
Stockholders Equity FY 2016 · Dec 31, 2016 −$3.14M
Current Liabilities FY 2016 · Dec 31, 2016 $4.39M
Current Liabilities FY 2016 · Dec 31, 2015 $3.83M
Total Liabilities FY 2016 · Dec 31, 2016 $4.4M
Total Liabilities FY 2016 · Dec 31, 2015 $3.83M
Current Assets FY 2016 · Dec 31, 2016 $940.82K
Current Assets FY 2016 · Dec 31, 2015 $30.78K
Total Assets FY 2016 · Dec 31, 2016 $1.11M
Total Assets FY 2016 · Dec 31, 2015 $37.3K
Sga Expense FY 2016 · Dec 31, 2016 $2.2M
Sga Expense FY 2016 · Dec 31, 2015 $2.75M
Rd Expense FY 2016 · Dec 31, 2016 $641.57K
Rd Expense FY 2016 · Dec 31, 2015 $361.48K
Net Income FY 2016 · Dec 31, 2016 −$2.92M
Net Income FY 2016 · Dec 31, 2015 −$3.7M
Operating Income FY 2016 · Dec 31, 2016 −$2.84M
Operating Income FY 2016 · Dec 31, 2015 −$3.11M